Tafamidis Meglumine Capsule — FDA Drug Shortage

No longer listed by FDA — Pfizer Inc.

The FDA lists a drug shortage record for Tafamidis Meglumine Capsule (capsule) from Pfizer Inc. with status No longer listed by FDA. The shortage was first posted on Sep 29, 2025.

Shortage details

Status
No longer listed by FDA
Company
Pfizer Inc.
Package NDC
0069-1975-40
Dosage Form
Capsule
Presentation
Vyndaqel, Capsule, 20 mg soft gelatin capsules; blister card (120 total capsules) (NDC 0069-1975-40)
Initial Posting
Sep 29, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.